New drug combo offers hope for tough blood disorder
NCT ID NCT04423367
Summary
This study tested a two-drug combination (bortezomib and dexamethasone) for adults with a rare blood disorder called acquired pure red cell aplasia, where the body stops making enough red blood cells. It was specifically for patients whose first treatment didn't work or stopped working. The main goal was to see if this new approach was safe and could help patients respond to treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED PURE RED CELL APLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regenerative Medicine Center
Tianjin, China
-
The Second Affilated Hospital of Shandong First Medical University
Tai’an, Shandong, China
-
Zhoukou Central Hospital
Zhoukou, Henan, China
Conditions
Explore the condition pages connected to this study.